These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6295615)

  • 1. Chemotherapy of malignant fibrous histiocytoma of bone. A report of five cases.
    Urban C; Rosen G; Huvos AG; Caparros B; Cacavio A; Nirenberg A
    Cancer; 1983 Mar; 51(5):795-802. PubMed ID: 6295615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant chemotherapy of malignant fibrous histiocytoma of bone.
    Weiner M; Sedlis M; Johnston AD; Dick HM; Wolff JA
    Cancer; 1983 Jan; 51(1):25-9. PubMed ID: 6295593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy.
    Rosen G; Caparros B; Huvos AG; Kosloff C; Nirenberg A; Cacavio A; Marcove RC; Lane JM; Mehta B; Urban C
    Cancer; 1982 Mar; 49(6):1221-30. PubMed ID: 6174200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery.
    Rosen G; Marcove RC; Caparros B; Nirenberg A; Kosloff C; Huvos AG
    Cancer; 1979 Jun; 43(6):2163-77. PubMed ID: 88251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of malignant fibrous histiocytoma of bone. A plea for primary chemotherapy.
    den Heeten GJ; Schraffordt Koops H; Kamps WA; Oosterhuis JW; Sleijfer DT; Oldhoff J
    Cancer; 1985 Jul; 56(1):37-40. PubMed ID: 2988736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of high-dose methotrexate-based neoadjuvant chemotherapy in malignant fibrous histiocytoma of bone.
    Ham SJ; Hoekstra HJ; van der Graaf WT; Kamps WA; Molenaar WM; Schraffordt Koops H
    J Clin Oncol; 1996 Feb; 14(2):490-6. PubMed ID: 8636762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in the response of primary osteogenic sarcoma to preoperative chemotherapy (high-dose methotrexate with citrovorum factor).
    Juergens H; Kosloff C; Nirenberg A; Mehta BM; Huvos AG; Rosen G
    Natl Cancer Inst Monogr; 1981 Apr; (56):221-6. PubMed ID: 6975439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathologic aspects of chemotherapy response in the treatment of osteogenic sarcoma. An analysis of two cases.
    Marroum MC; Huvos AG; Rosen G
    Oncology; 1977; 34(6):273-80. PubMed ID: 304199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telangiectatic osteogenic sarcoma. Improved survival with combination chemotherapy.
    Rosen G; Huvos AG; Marcove R; Nirenberg A
    Clin Orthop Relat Res; 1986 Jun; (207):164-73. PubMed ID: 2424660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant chemotherapy with doxorubicin and cisplatin in malignant fibrous histiocytoma of bone: A European Osteosarcoma Intergroup study.
    Bramwell VH; Steward WP; Nooij M; Whelan J; Craft AW; Grimer RJ; Taminau AH; Cannon SR; Malcolm AJ; Hogendoorn PC; Uscinska B; Kirkpatrick AL; Machin D; Van Glabbeke MM
    J Clin Oncol; 1999 Oct; 17(10):3260-9. PubMed ID: 10506628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neoadjuvant chemotherapy in malignant fibrous histiocytoma of the extremities. Preliminary results in 10 cases treated preoperatively with methotrexate and cisplatin].
    Bettelli G; Avella M; Capanna R; Dallari D; Picci P; Campanacci M; Bacci G
    Chir Organi Mov; 1987; 72(2):111-7. PubMed ID: 2824137
    [No Abstract]   [Full Text] [Related]  

  • 12. The effectiveness of chemotherapy in localized malignant fibrous histiocytoma (MFH) of bone: the Rizzoli Institute experience with 66 patients treated with surgery alone or surgery + adjuvant or neoadjuvant chemotherapy.
    Bacci G; Avella M; Picci P; Capanna R; Fontana M; Dallari D; Campanacci M
    Chemioterapia; 1988 Dec; 7(6):406-13. PubMed ID: 2851393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy for high grade malignant fibrous histiocytoma of bone.
    Bacci G; Picci P; Mercuri M; Bertoni F; Ferrari S
    Clin Orthop Relat Res; 1998 Jan; (346):178-89. PubMed ID: 9577426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteogenic sarcoma: eight-percent, three-year, disease-free survival with combination chemotherapy (T-7).
    Rosen G; Nirenberg A; Caparros B; Juergens H; Kosloff C; Mehta BM; Marcove RC; Huvos AG
    Natl Cancer Inst Monogr; 1981 Apr; (56):213-20. PubMed ID: 6946291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy of malignant fibrous histiocytoma of bone.
    Earl HM; Pringle J; Kemp H; Morittu L; Miles D; Souhami R
    Ann Oncol; 1993 May; 4(5):409-15. PubMed ID: 8394734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteogenic sarcoma. Malignant fibrous histiocytoma subtype.
    Ballance WA; Mendelsohn G; Carter JR; Abdul-Karim FW; Jacobs G; Makley JT
    Cancer; 1988 Aug; 62(4):763-71. PubMed ID: 2840191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant chemotherapy for malignant fibrous histiocytoma of bone and for osteosarcoma of the limbs: a comparison between the results obtained for 21 and 144 patients, respectively, treated during the same period with the same chemotherapy protocol.
    Bacci G; Mercuri M; Ruggieri P; Ferraro A; Bertoni F; Tella G; Ferrari S; Iantorno D
    Chir Organi Mov; 1996; 81(2):139-53. PubMed ID: 8968117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant transformation of a giant cell tumor 25 years after initial treatment.
    Mori Y; Tsuchiya H; Karita M; Nonomura A; Nojima T; Tomita K
    Clin Orthop Relat Res; 2000 Dec; (381):185-91. PubMed ID: 11127655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant chemotherapy for osteogenic sarcoma.
    Etcubanas E; Wilbur JR
    Cancer Treat Rep; 1978 Feb; 62(2):283-7. PubMed ID: 346218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy, en bloc resection, and prosthetic bone replacement in the treatment of osteogenic sarcoma.
    Rosen G; Murphy ML; Huvos AG; Gutierrez M; Marcove RC
    Cancer; 1976 Jan; 37(1):1-11. PubMed ID: 1082364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.